May 19, 2021 - Politics
Colorado aims to set stricter limits on cannabis concentrates, medical marijuana
Data: Colorado Department of Revenue, 2019. Chart: Michelle McGhee/Axios

Colorado leaders want to make it harder to get high-potency marijuana concentrates, but a new bill that advanced Tuesday stops short of imposing THC caps.

Why it matters: Backed by Colorado Attorney General Phil Weiser, the legislation represents a rare effort to crack down on the state's first-in-the nation marijuana industry.

What's happening: The legislation aims to make it harder for medical marijuana — which enjoys fewer regulations — to get passed to others by:

  • Requiring a doctor to take more steps to authorize a medical marijuana card, particularly for those aged 18-20.
  • Creating a medical marijuana purchase tracking system to prevent looping, in which patients can visit multiple stores to exceed the per-purchase cap.
  • Limiting most single-day purchases to 8 grams, instead of the current 40 grams.

Other elements of the legislation require the state to conduct a public information campaign about high-potency THC; provide $3 million for scientific research; and set rules for new individual packaging.

What they're saying: A Medical Center of Aurora psychiatrist called cannabis use and addiction an "emerging epidemic ... that threatens to swallow the lives of a whole generation of Coloradans."

  • Weiser, a Democrat, called teenage use of high-THC products "a critical public health challenge."

Get smart: Concentrates — such as vape cartridges, wax, dab and shatter — represent about one-third of the state's marijuana market.

  • The average potency of concentrates is 69%, compared to 18% for a pre-rolled joint.
  • Since adult-use legalization in 2014, concentrate sales increased eightfold, faster than any other type of product.
  • A 2019 survey of Colorado high school students found 10% dabbed at least once in the last 30 days, compared to 7% in 2017.

Between the lines: The legislation is actually a political win for the cannabis industry because the sponsors did not include potency caps as initially planned, and top advocates are supportive of the intent.

  • Still, the industry wants to see the language about the research change because they say it would likely produce a predetermined negative outcome.
  • The Marijuana Industry Group also opposes the lower limits on medical marijuana purchases.

Get more local stories in your inbox with Axios Denver.

More Denver stories

No stories could be found


Get a free daily digest of the most important news in your backyard with Axios Denver.